MDA-MB-453（人乳腺癌細(xì)胞）
CBP60386
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | MDA-MB-453 |
| Background: | MDA-MB-453 was derived in 1976 by R. Cailleau et al. from an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities. |
| Species: | Homo sapiens, human |
| Tissue: | mammary gland/breast; derived from metastatic site: pericardial effusion |
| Disease: | metastatic carcinoma |
| Gender: | female, 48 years, Caucasian |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 10,12 D13S317: 12 D16S539: 9 D5S818: 11 D7S820: 10 THO1: 6 TPOX: 10 vWA: 17,18 Our Cell Line Authentication Service |
| Culture Medium: |
DMEM+ 10% FBS MDA-MB-453完全培養(yǎng)基，# CBP60386M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Receptor Expression: | fibroblast growth factor (FGF), expressed |
| Tumor Formation: | No, in immunosuppressed mice Yes, in semisolid medium |
| Comments: | The cells overexpress FGF receptors. For more information, please contact us (4008-750-250). |
